The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
Title |
Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case report
|
---|---|
Published in |
Frontiers in oncology, December 2022
|
DOI | 10.3389/fonc.2022.1086677 |
Pubmed ID | |
Authors |
Veronika Blum, Vanghelita Andrei, Baptiste Ameline, Silvia Hofer, Bruno Fuchs, Klaus Strobel, Anna Allemann, Beata Bode, Daniel Baumhoer |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 33% |
Netherlands | 1 | 33% |
Switzerland | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Scientists | 1 | 33% |
Members of the public | 1 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 December 2022.
All research outputs
#16,283,598
of 26,180,771 outputs
Outputs from Frontiers in oncology
#5,183
of 22,919 outputs
Outputs of similar age
#233,951
of 492,925 outputs
Outputs of similar age from Frontiers in oncology
#337
of 1,472 outputs
Altmetric has tracked 26,180,771 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,919 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 492,925 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 1,472 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.